Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Fred E Cohen

Director at Intellia Therapeutics, Inc. (NTLA)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return+33.8%
vs. S&P 500+37.9%
Beat the market100%
Paper profit on buys+$558K
Total bought / sold$1.4M / $0

Reported trades

Filed Stock Type Shares Price Value Since
Jan 7SEC NTLAIntellia Therapeutics, Inc. Buy 150,000207,453 held (+261%) $9.35 $1.4M +39.8%
  • Buy

    Director Fred E Cohen bought $1.4M of NTLA at $9.35 — first open-market purchase in our records; raises the stake by 261%.